Salma Jivan, BS

Specialist

Publications

Ronald JA, Kim BS, Gowrishankar G, Namavari M, Alam IS, D'Souza A, Nishikii H, Chuang HY, Ilovich O, Lin CF, Reeves R, Shuhendler A, Hoehne A, Chan CT, Baker J, Yaghoubi SS, VanBrocklin HF, Hawkins R, Franc BL, Jivan S, Slater JB, Verdin EF, Gao KT, Benjamin J, Negrin R, Gambhir SS. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant. Cancer Res. 2017 Jun 01; 77(11):2893-2902.
Franc BL, Goth S, MacKenzie J, Li X, Blecha J, Lam T, Jivan S, Hawkins RA, VanBrocklin H. In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis. Mol Imaging. 2017 Jan 01; 16:1536012117712638.
Dannoon S, Ganguly T, Cahaya H, Geruntho JJ, Galliher MS, Beyer SK, Choy CJ, Hopkins MR, Regan M, Blecha JE, Skultetyova L, Drake CR, Jivan S, Barinka C, Jones EF, Berkman CE, VanBrocklin HF. Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer. J Med Chem. 2016 Jun 23; 59(12):5684-94.
Hope TA, Pampaloni MH, Nakakura E, VanBrocklin H, Slater J, Jivan S, Aparici CM, Yee J, Bergsland E. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor. Abdom Imaging. 2015 Aug; 40(6):1432-40.
Ganguly T, Dannoon S, Hopkins MR, Murphy S, Cahaya H, Blecha JE, Jivan S, Drake CR, Barinka C, Jones EF, VanBrocklin HF, Berkman CE. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. Nucl Med Biol. 2015 Oct; 42(10):780-7.
Sossi V, Dinelle K, Jivan S, Fischer K, Holden JE, Doudet D. In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET. J Nucl Med. 2012 May; 53(5):813-22.
Landau AM, Clark C, Jivan S, Doudet DJ. Antiparkinsonian mechanism of electroconvulsive therapy in MPTP-lesioned non-human primates. Neurodegener Dis. 2012; 9(3):128-38.
Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage. 2006 Mar; 30(1):26-35.
Strome EM, Jivan S, Doudet DJ. Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors. J Neurosci Methods. 2005 Jan 30; 141(1):143-54.
Studenov AR, Jivan S, Adam MJ, Ruth TJ, Buckley KR. Studies of the mechanism of the in-loop synthesis of radiopharmaceuticals. Appl Radiat Isot. 2004 Dec; 61(6):1195-201.
Buckley KR, Jivan S, Ruth TJ. Improved yields for the in situ production of [11C]CH4 using a niobium target chamber. Nucl Med Biol. 2004 Aug; 31(6):825-7.
Doudet DJ, Jivan S, Holden JE. In vivo measurement of receptor density and affinity: comparison of the routine sequential method with a nonsequential method in studies of dopamine D2 receptors with [11C]raclopride. J Cereb Blood Flow Metab. 2003 Mar; 23(3):280-4.
Barnhart TE, Converse AK, Dabbs KA, Nickles RJ, Buckley K, Jivan S, Ruth TJ, Roberts AD. Water-cooled grid support for high-power irradiation with thin target windows. Appl Radiat Isot. 2003 Jan; 58(1):21-6.
Holden JE, Jivan S, Ruth TJ, Doudet DJ. In vivo receptor assay with multiple ligand concentrations: an equilibrium approach. J Cereb Blood Flow Metab. 2002 Sep; 22(9):1132-41.
Doudet DJ, Jivan S, Ruth TJ, Holden JE. Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys: PET studies with [11C]raclopride. Synapse. 2002 Jun 01; 44(3):198-202.
Doudet DJ, Jivan S, Ruth TJ, Wyatt RJ. In vivo PET studies of the dopamine D1 receptors in rhesus monkeys with long-term MPTP-induced Parkinsonism. Synapse. 2002 May; 44(2):111-5.
Ruth TJ, Buckle KR, Chun KS, Hurtado ET, Jivan S, Zeisler S. A proof of principle for targetry to produce ultra high quantities of 18F-fluoride. Appl Radiat Isot. 2001 Oct; 55(4):457-61.
de la Fuente-Fernández R, Lu JQ, Sossi V, Jivan S, Schulzer M, Holden JE, Lee CS, Ruth TJ, Calne DB, Stoessl AJ. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover. Ann Neurol. 2001 Mar; 49(3):298-303.
Doudet DJ, Holden JE, Jivan S, McGeer E, Wyatt RJ. In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism. Synapse. 2000 Nov; 38(2):105-13.
Doudet DJ, Chan GL, Jivan S, DeJesus OT, McGeer EG, English C, Ruth TJ, Holden JE. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine. J Cereb Blood Flow Metab. 1999 Mar; 19(3):278-87.
Adam MJ, Grierson JR, Jivan S. An improved HPLC system for the analysis and purification of organic amine radiopharmaceuticals. Int J Rad Appl Instrum A. 1989; 40(1):91-2.
Adam MJ, Ruth TJ, Jivan S, Pate BD. The use of C-18 SEP PAK cartridges to simplify routine production of 2-deoxy-2-[18F]fluoro-D-glucose. Int J Appl Radiat Isot. 1984 Oct; 35(10):985-6.